Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

L-Carnitine and Reduced Systolic Blood Pressure

Research synthesisLow evidenceSmall effect3 studies · 0 beneficial · 3 neutral · 0 harmful

Across 3 studies, none found a statistically significant beneficial effect of L-carnitine supplementation on systolic blood pressure. All studies reported small effect sizes but neutral results. The median study duration was 56 days, and the only study that specified a dose used 1000 mg/day of L-carnitine tartrate.

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. None of the included studies reached statistical significance for L-carnitine alone on systolic blood pressure. The meta-analysis reported high heterogeneity (I2=85%), indicating variability across trials. One RCT found that L-carnitine combined with synbiotic reduced SBP, but L-carnitine monotherapy did not.

Generated Jul 12, 2026
Doses used in studies
  • Tartrate · mg/day: 1,000 (median 1,000, IQR 1,0001,000) 1 study
Time to effect
Median: 8 weeks · IQR 8 weeks8 weeks · Range 8 weeks8 weeks — Reported in 1 of 3 studies
3 of 3 papers
Back to top